Literature DB >> 1603903

Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.

P J Brent1, G Bot.   

Abstract

The effects of morphine D-Pen2, D-Pen5 enkephalin (DPDPE) and U50,488H on the behavioural syndrome elicited by the dopamine (DA) D-2 agonist quinpirole, were investigated. Morphine (1, 5 and 15 mg/kg SC) and morphine administered intracerebroventricularly (ICV) (2 x 5 microliters, 10(-3) M; total dose = 10 nmol) produced piloerection and sedation. DPDPE-ICV (2 x 5 microliters and 2 x 10 microliters, 10(-3) M; total doses = 10 and 20 nmol) produced piloerection and sedation similar to morphine. U50,488H (1 mg/kg SC) induced locomotor activity and some stereotyped behaviour, whereas U50,488H (5 and 10 mg/kg SC) induced muscle rigidity and dystonic-like movements. The locomotor and behavioural response elicited by quinpirole (3 mg/kg IP) was attenuated in guinea-pigs pretreated with morphine (1, 5 and 15 mg/kg SC), morphine-ICV (2 x 5 microliters, 10(-3) M), and DPDPE-ICV (2 x 5 microliters and 2 x 10 microliters, 10(-3) M). These effects were reversed by naloxone (15 mg/kg SC). U50,488H (1 mg/kg SC) increased the quinpirole-induced locomotor activity, whereas U50,488H (5 and 10 mg/kg SC) decreased the locomotor activity and stereotyped behaviours produced by quinpirole. These results indicate that the gross behavioural effects of mu, delta and kappa opioids differ in guinea-pigs compared to other rodent species, and suggest differential involvement of these opioid receptor subtypes with DA D-2 receptor-mediated activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1603903     DOI: 10.1007/bf02245274

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.

Authors:  R Maldonado; V Daugé; J Feger; B P Roques
Journal:  Neuropharmacology       Date:  1990-03       Impact factor: 5.250

2.  Increased plasma catecholamines and locomotor activity induced by centrally administered substance P in guinea-pigs.

Authors:  P J Brent; P A Johnston; L A Chahl
Journal:  Neuropharmacology       Date:  1988-07       Impact factor: 5.250

3.  Changes in dopamine receptors in mouse striatum following morphine treatments.

Authors:  S de la Baume; G Patey; H Marçais; P Protais; J Costentin; J C Schwartz
Journal:  Life Sci       Date:  1979-06-18       Impact factor: 5.037

4.  The behavioural effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus.

Authors:  E M Joyce; G F Koob; R Strecker; S D Iversen; F E Bloom
Journal:  Brain Res       Date:  1981-09-28       Impact factor: 3.252

5.  Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.

Authors:  P A Johnston; L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

6.  Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.

Authors:  E Sineger; K Horváth; E Miglécz; I Tarnawa; F Andrási; J I Székely
Journal:  Eur J Pharmacol       Date:  1982-06-04       Impact factor: 4.432

7.  Binding of [3H]spiroperidol to striatal membranes of rats treated chronically with morphine. Influence of Pro-Leu-Gly-NH2 and cyclo(Leu-Gly).

Authors:  H N Bhargava
Journal:  Neuropharmacology       Date:  1983-12       Impact factor: 5.250

8.  Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia.

Authors:  G Fredow; W Löscher
Journal:  Eur J Pharmacol       Date:  1991-01-10       Impact factor: 4.432

9.  Chronically administered morphine increases dopamine receptor sensitivity in mice.

Authors:  J R Martin; A E Takemori
Journal:  Eur J Pharmacol       Date:  1986-02-18       Impact factor: 4.432

10.  Ultrastructural evidence of dopaminergic input to enkephalinergic neurons in rat neostriatum.

Authors:  Y Kubota; S Inagaki; S Kito; H Takagi; A D Smith
Journal:  Brain Res       Date:  1986-03-05       Impact factor: 3.252

View more
  4 in total

1.  Kappa-opioid receptor agonist U50448H protects against renal ischemia-reperfusion injury in rats via activating the PI3K/Akt signaling pathway.

Authors:  Li-Jie Liu; Jian-Jun Yu; Xiao-Lin Xu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Effects of kappa opioid receptors on conditioned place aversion and social interaction in males and females.

Authors:  Cindee F Robles; Marissa Z McMackin; Katharine L Campi; Ian E Doig; Elizabeth Y Takahashi; Michael C Pride; Brian C Trainor
Journal:  Behav Brain Res       Date:  2014-01-18       Impact factor: 3.332

3.  Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.

Authors:  Yu-Jun Wang; Khampaseuth Rasakham; Peng Huang; Darina Chudnovskaya; Alan Cowan; Lee-Yuan Liu-Chen
Journal:  J Pharmacol Exp Ther       Date:  2011-08-12       Impact factor: 4.030

4.  Morphine and naltrexone modulate D2 but not D1 receptor induced motor behavior in MPTP-lesioned monkeys.

Authors:  R J Vermeulen; B Drukarch; M C Sahadat; C Goosen; A N Schoffelmeer; E C Wolters; J C Stoof
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.